Provided by Tiger Trade Technology Pte. Ltd.

LandBridge Co. LLC

89.71
+2.683.08%
Pre-market: 89.00-0.7100-0.79%04:05 EDT
Volume:458.55K
Turnover:41.28M
Market Cap:6.92B
PE:79.39
High:91.69
Open:87.50
Low:87.50
Close:87.03
52wk High:91.69
52wk Low:43.75
Shares:77.09M
Float Shares:27.69M
Volume Ratio:1.32
T/O Rate:1.66%
Dividend:0.44
Dividend Rate:0.49%
EPS(TTM):1.13
EPS(LYR):0.9358
ROE:11.52%
ROA:7.07%
PB:19.45
PE(LYR):95.86

Loading ...

Landbridge Co Llc Q1 Revenue USD 51 Million VS. Ibes Estimate USD 58.7 Million

THOMSON REUTERS
·
May 07

Landbridge Co Llc Q1 Adjusted Ebitda Margin 88%

THOMSON REUTERS
·
May 07

LandBridge announces annual shareholder meeting

Reuters
·
May 01

Earning Preview: LandBridge Co. LLC revenue this quarter is expected to increase by 34.08%, and institutions skew bullish

Earnings Agent
·
Apr 30

LB Group's Attributable Profit Slides 43% in 2025

MT Newswires Live
·
Apr 28

Wells Fargo Sticks to Its Buy Rating for LandBridge Company LLC Class A (LB)

TIPRANKS
·
Apr 27

LB Pharmaceuticals Initiated at Buy by HC Wainwright & Co.

Dow Jones
·
Apr 27

HC Wainwright Initiates Coverage on LB Pharmaceuticals With Buy Rating, $45 Price Target

MT Newswires Live
·
Apr 27

LB Pharmaceuticals initiated with a Buy at H.C. Wainwright

TIPRANKS
·
Apr 27

Analysts Offer Insights on Healthcare Companies: LB Pharmaceuticals, Inc. (LBRX) and West Pharmaceutical Services (WST)

TIPRANKS
·
Apr 24

Piper Sandler Reaffirms Their Buy Rating on LB Pharmaceuticals, Inc. (LBRX)

TIPRANKS
·
Apr 23

LIXTE Biotechnology Holdings (NASDAQ: LIXT) Positions LB-100 as Novel Approach in Cancer Treatment Landscape

TIPRANKS
·
Apr 21

LB-102 Bipolar Depression Trial Moves Forward: What LBRX Investors Should Know

TIPRANKS
·
Apr 19

LB Pharmaceuticals, Inc. (LBRX) Gets a Buy from Roth MKM

TIPRANKS
·
Apr 15

Barclays Issues a Hold Rating on LandBridge Company LLC Class A (LB)

TIPRANKS
·
Apr 14

LandBridge schedules first-quarter earnings release and conference call

Reuters
·
Apr 14

LB Pharmaceuticals Initiated at Buy by Craig-Hallum

Dow Jones
·
Apr 11

Lixte Biotech Holdings (NASDAQ: LIXT) Advances Precision Oncology Strategy with LB-100, Expands Clinical and Strategic Partnerships

TIPRANKS
·
Apr 11

LB Pharmaceuticals initiated with a Buy at Craig-Hallum

TIPRANKS
·
Apr 10

LB Pharmaceuticals Announces Presentation at 25th Annual Needham Virtual Healthcare Conference

GlobeNewswire
·
Apr 10